CN111298184A - 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 - Google Patents
可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 Download PDFInfo
- Publication number
- CN111298184A CN111298184A CN202010310031.2A CN202010310031A CN111298184A CN 111298184 A CN111298184 A CN 111298184A CN 202010310031 A CN202010310031 A CN 202010310031A CN 111298184 A CN111298184 A CN 111298184A
- Authority
- CN
- China
- Prior art keywords
- layer
- bandage
- coaxial
- preparation
- shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002121 nanofiber Substances 0.000 title claims abstract description 65
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 229940079593 drug Drugs 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000010410 layer Substances 0.000 claims abstract description 111
- 108010010803 Gelatin Proteins 0.000 claims abstract description 35
- 229920002494 Zein Polymers 0.000 claims abstract description 35
- 239000008273 gelatin Substances 0.000 claims abstract description 35
- 229920000159 gelatin Polymers 0.000 claims abstract description 35
- 235000019322 gelatine Nutrition 0.000 claims abstract description 35
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 35
- 239000005019 zein Substances 0.000 claims abstract description 35
- 229940093612 zein Drugs 0.000 claims abstract description 35
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 34
- 238000010041 electrostatic spinning Methods 0.000 claims abstract description 27
- 239000012792 core layer Substances 0.000 claims abstract description 26
- 229920001661 Chitosan Polymers 0.000 claims abstract description 24
- 239000000835 fiber Substances 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 230000004048 modification Effects 0.000 claims abstract description 18
- 238000012986 modification Methods 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 13
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims description 73
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 54
- 238000009987 spinning Methods 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000011259 mixed solution Substances 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 7
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 claims description 6
- 229960003128 mupirocin Drugs 0.000 claims description 6
- 229930187697 mupirocin Natural products 0.000 claims description 6
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 claims description 6
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960000723 ampicillin Drugs 0.000 claims description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 229960003260 chlorhexidine Drugs 0.000 claims description 4
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 4
- 229940106681 chloroacetic acid Drugs 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 4
- 238000006266 etherification reaction Methods 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 9
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 7
- 239000013543 active substance Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229960003600 silver sulfadiazine Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
实施例 | 外针头流速 | 内针头流速 |
实施例1 | 1.0mL/h | 0.4mL/h |
实施例10 | 0.8mL/h | 0.4mL/h |
实施例11 | 1.0mL/h | 0.2mL/h |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010310031.2A CN111298184B (zh) | 2020-04-20 | 2020-04-20 | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010310031.2A CN111298184B (zh) | 2020-04-20 | 2020-04-20 | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111298184A true CN111298184A (zh) | 2020-06-19 |
CN111298184B CN111298184B (zh) | 2020-12-18 |
Family
ID=71162732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010310031.2A Active CN111298184B (zh) | 2020-04-20 | 2020-04-20 | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111298184B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112281303A (zh) * | 2020-10-27 | 2021-01-29 | 福建师范大学 | 一种生物友好型医用肋骨骨折绷带制备装置 |
CN112315660A (zh) * | 2020-12-23 | 2021-02-05 | 广州牧蓝春生物科技有限公司 | 一种可生物降解的纳米纤维医用绷带及其制备方法 |
CN113398314A (zh) * | 2021-06-11 | 2021-09-17 | 长春工业大学 | 一种手持静电纺丝单向导液伤口敷料的制备方法 |
CN113417074A (zh) * | 2021-05-24 | 2021-09-21 | 江苏省农业科学院 | 一种抑菌纳米纤维膜的制备方法 |
CN114288458A (zh) * | 2021-12-06 | 2022-04-08 | 盐城工学院 | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101491688A (zh) * | 2008-01-23 | 2009-07-29 | 王学洲 | 可溶性止血纱布及其制备方法 |
WO2011137292A2 (en) * | 2010-04-30 | 2011-11-03 | University Of Maryland, Baltimore | Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering |
CN102817105A (zh) * | 2012-08-24 | 2012-12-12 | 上海交通大学 | 核壳结构合成高分子-天然高分子复合纤维的制备方法 |
CN102908665A (zh) * | 2012-10-26 | 2013-02-06 | 东华大学 | 用串珠纤维担载蛋白颗粒的组织工程纤维支架的制备方法 |
CN103611182A (zh) * | 2013-12-10 | 2014-03-05 | 东华大学 | 一种医用敷料用核-壳结构超细纤维载体材料的制备方法 |
CN104096272A (zh) * | 2013-04-03 | 2014-10-15 | 中国科学院化学研究所 | 用于手术后抗感染的复合静电纺丝纳米纤维膜疝修补片及其制备方法 |
CN105709280A (zh) * | 2014-12-18 | 2016-06-29 | 上海微创医疗器械(集团)有限公司 | 一种抗感染包覆袋及其制备方法 |
CN107137748A (zh) * | 2017-06-27 | 2017-09-08 | 湖北中创医疗用品有限公司 | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 |
CN110180013A (zh) * | 2019-05-31 | 2019-08-30 | 上海纳米技术及应用国家工程研究中心有限公司 | 覆膜型医用烧伤防粘连型纱布绷带的制备方法及其产品和应用 |
CN110195294A (zh) * | 2019-07-05 | 2019-09-03 | 四川大学 | 一种双负载核/壳结构的纳米纤维膜及其制备方法 |
CN110229247A (zh) * | 2019-06-30 | 2019-09-13 | 海南师范大学 | 基于海藻酸衍生物电纺纳米复合纤维膜医用敷料及其制备方法 |
CN110302417A (zh) * | 2019-06-18 | 2019-10-08 | 珠海稻田医疗科技有限公司 | 一种抗菌、生物降解的医用缝合线 |
CN110433325A (zh) * | 2019-07-26 | 2019-11-12 | 杭州中科润德生物技术发展有限公司 | 一种蛋白类高分子纳米纤维止血材料及其制备方法和应用 |
CN110565207A (zh) * | 2019-07-24 | 2019-12-13 | 苏州大学 | 一种纤维材料及其制备方法和应用 |
-
2020
- 2020-04-20 CN CN202010310031.2A patent/CN111298184B/zh active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101491688A (zh) * | 2008-01-23 | 2009-07-29 | 王学洲 | 可溶性止血纱布及其制备方法 |
WO2011137292A2 (en) * | 2010-04-30 | 2011-11-03 | University Of Maryland, Baltimore | Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering |
CN102817105A (zh) * | 2012-08-24 | 2012-12-12 | 上海交通大学 | 核壳结构合成高分子-天然高分子复合纤维的制备方法 |
CN102908665A (zh) * | 2012-10-26 | 2013-02-06 | 东华大学 | 用串珠纤维担载蛋白颗粒的组织工程纤维支架的制备方法 |
CN104096272A (zh) * | 2013-04-03 | 2014-10-15 | 中国科学院化学研究所 | 用于手术后抗感染的复合静电纺丝纳米纤维膜疝修补片及其制备方法 |
CN103611182A (zh) * | 2013-12-10 | 2014-03-05 | 东华大学 | 一种医用敷料用核-壳结构超细纤维载体材料的制备方法 |
CN105709280A (zh) * | 2014-12-18 | 2016-06-29 | 上海微创医疗器械(集团)有限公司 | 一种抗感染包覆袋及其制备方法 |
CN107137748A (zh) * | 2017-06-27 | 2017-09-08 | 湖北中创医疗用品有限公司 | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 |
CN110180013A (zh) * | 2019-05-31 | 2019-08-30 | 上海纳米技术及应用国家工程研究中心有限公司 | 覆膜型医用烧伤防粘连型纱布绷带的制备方法及其产品和应用 |
CN110302417A (zh) * | 2019-06-18 | 2019-10-08 | 珠海稻田医疗科技有限公司 | 一种抗菌、生物降解的医用缝合线 |
CN110229247A (zh) * | 2019-06-30 | 2019-09-13 | 海南师范大学 | 基于海藻酸衍生物电纺纳米复合纤维膜医用敷料及其制备方法 |
CN110195294A (zh) * | 2019-07-05 | 2019-09-03 | 四川大学 | 一种双负载核/壳结构的纳米纤维膜及其制备方法 |
CN110565207A (zh) * | 2019-07-24 | 2019-12-13 | 苏州大学 | 一种纤维材料及其制备方法和应用 |
CN110433325A (zh) * | 2019-07-26 | 2019-11-12 | 杭州中科润德生物技术发展有限公司 | 一种蛋白类高分子纳米纤维止血材料及其制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
MIN HE ET AL: "Fabrication of metronidazole loaded poly (e-caprolactone)/zein core/", 《JOURNAL OF COLLOID AND INTERFACE SCIENCE》 * |
何敏: "同轴纺丝制备载药型引导组织再生膜", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
邓伶俐: "基于静电纺丝技术的明胶复合纳米纤维的构建及其应用研究", 《中国博士学位论文全文数据库 工程科技Ⅰ辑》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112281303A (zh) * | 2020-10-27 | 2021-01-29 | 福建师范大学 | 一种生物友好型医用肋骨骨折绷带制备装置 |
CN112315660A (zh) * | 2020-12-23 | 2021-02-05 | 广州牧蓝春生物科技有限公司 | 一种可生物降解的纳米纤维医用绷带及其制备方法 |
CN113417074A (zh) * | 2021-05-24 | 2021-09-21 | 江苏省农业科学院 | 一种抑菌纳米纤维膜的制备方法 |
CN113398314A (zh) * | 2021-06-11 | 2021-09-17 | 长春工业大学 | 一种手持静电纺丝单向导液伤口敷料的制备方法 |
CN114288458A (zh) * | 2021-12-06 | 2022-04-08 | 盐城工学院 | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 |
CN114288458B (zh) * | 2021-12-06 | 2023-03-14 | 盐城工学院 | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111298184B (zh) | 2020-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111298184B (zh) | 可生物降解载药纳米纤维烧伤科用医用绷带及其制备方法 | |
Ambekar et al. | Advancements in nanofibers for wound dressing: A review | |
Pilehvar-Soltanahmadi et al. | An overview on application of natural substances incorporated with electrospun nanofibrous scaffolds to development of innovative wound dressings | |
Liu et al. | Recent development of electrospun wound dressing | |
Wsoo et al. | A review on the properties of electrospun cellulose acetate and its application in drug delivery systems: A new perspective | |
Wang et al. | Functional electrospun fibers for the treatment of human skin wounds | |
Chen et al. | Recent advances in electrospun nanofibers for wound dressing | |
Zhao et al. | Preparation of nanofibers with renewable polymers and their application in wound dressing | |
CN108324986B (zh) | 一种急性创伤用多功能有序释药医用敷膜及其制备方法 | |
Kumar et al. | A review on polysaccharides mediated electrospun nanofibers for diabetic wound healing: their current status with regulatory perspective | |
Rieger et al. | Designing electrospun nanofiber mats to promote wound healing–a review | |
Joshi et al. | Advances in topical drug delivery system: Micro to nanofibrous structures | |
WO2020186714A1 (zh) | 一种载药纳米复合纤维膜系统及其制备方法和应用 | |
CN107237005B (zh) | 一种海藻酸与壳聚糖双组份纤维及其制备方法 | |
WO2020186715A1 (zh) | 一种载药纳米纤维膜及其制备方法和应用 | |
CN107137748B (zh) | 一种核壳静电纺丝壳聚糖纳米纤维伤口敷料及其制备方法 | |
Coelho et al. | Electrospinning technology: designing nanofibers toward wound healing application | |
Mirzaei et al. | Herbal extract loaded chitosan-based nanofibers as a potential wound-dressing | |
Palanisamy et al. | A critical review on starch-based electrospun nanofibrous scaffolds for wound healing application | |
Sadeghi-Aghbash et al. | Wound healing: an overview of wound dressings on health care | |
CN114288458B (zh) | 一种免绷带固定的抗菌防粘连纳米纤维敷料及其制备方法 | |
Al-Moalemi et al. | Electrospun sodium alginate/poly (ethylene oxide) nanofibers for wound healing applications: Challenges and future directions | |
Shi et al. | Spatially engineering tri-layer nanofiber dressings featuring asymmetric wettability for wound healing | |
Zheng et al. | Functional electrospun nanofibers: Fabrication, properties, and applications in wound-healing process | |
Yu et al. | Fabrication of alginate fibers loaded with silver nanoparticles biosynthesized via Dolcetto grape leaves (Vitis vinifera cv.): morphological, antimicrobial characterization and in vitro release studies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.29-31 Huancheng North Road, Panlong District, Kunming City, Yunnan Province Applicant after: Zhang Bingqi Address before: 350005 No. 102, Gudong Road, Gulou District, Fuzhou City, Fujian Province Applicant before: Zhang Bingqi |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201202 Address after: 246000 D4-B-2 Workshop of Jiabao Industrial Park, Anqing City, Anhui Province Applicant after: ANHUI MEDPUREST MEDICAL TECHNOLOGY Co.,Ltd. Address before: No.29-31 Huancheng North Road, Panlong District, Kunming City, Yunnan Province Applicant before: Zhang Bingqi |
|
GR01 | Patent grant | ||
GR01 | Patent grant |